{"id":547057,"date":"2021-06-10T18:00:01","date_gmt":"2021-06-10T18:00:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=547057"},"modified":"2021-06-10T18:00:01","modified_gmt":"2021-06-10T18:00:01","slug":"the-dynamics-of-rett-syndrome-market-is-anticipated-to-change-in-the-upcoming-years-owing-to-the-improvement-in-the-research-and-development","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/the-dynamics-of-rett-syndrome-market-is-anticipated-to-change-in-the-upcoming-years-owing-to-the-improvement-in-the-research-and-development_547057.html","title":{"rendered":"The dynamics of Rett Syndrome market is anticipated to change in the upcoming years owing to the improvement in the research and development"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1623325079.png\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"The dynamics of Rett Syndrome market is anticipated to change in the upcoming years owing to the improvement in the research and development \" src=\"https:\/\/www.abnewswire.com\/uploads\/1623325079.png\" alt=\"The dynamics of Rett Syndrome market is anticipated to change in the upcoming years owing to the improvement in the research and development \" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\">\n<div>Rett Syndrome Market <\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">The total market size for Rett Syndrome will include both emerging therapies, such as NNZ-2566 , GWP42003-P, ANAVEX 2-73 and Dojolvi, as well as current treatment regimens.<\/div>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/uploads\/deb97f847b69dc9b3f4d13878e87d185.jpg\" alt=\"\" \/><\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>The <\/span><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/rett-syndrome-market?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Rett Syndrome Market report<\/a><\/strong>&nbsp;<span>from DelveInsight provides an in-depth understanding of the Rett Syndrome, historical and forecasted epidemiology, as well as Rett Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Some of the Important Findings from the Rett Syndrome Market Report<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>According to research by M. Itoh et al. titled &#8220;Epidemiological study of Japanese Rett syndrome,&#8221; the prevalence of Rett Syndrome in Japan is <\/span><strong>0.90 per 10,000 females.<\/strong><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">According to a research undertaken by the European Union&#8217;s Health Programme, the estimated prevalence of Rett Syndrome in Europe is<strong> 10.0 per 100,000<\/strong>, with a birth prevalence of <strong>5.0 per 100,000.<\/strong><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">According to the National Congenital Anomaly and Rare Diseases Registration Service (NCARDRS), Rett Syndrome affects roughly one out of every <strong>12,000 females<\/strong> born each year globally, and it is rarely found in men.<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>According to the National Organization for Rare Disorders, Rett syndrome affects one <\/span><span>out of every <strong>10,000 girls<\/strong><\/span><span> in the United States by the age of 12.<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><strong>NNZ-2566 (Trofinetide)<\/strong><span> (Neuren Pharmaceuticals\/Acadia Pharmaceuticals), <\/span><strong>GWP42003-P (Epidiolex)<\/strong><span> (GW Research), <\/span><strong>ANAVEX 2-73 (blarcamesine)<\/strong><span> (Anavex Life Sciences), <\/span><strong>Dojolvi<\/strong><span> (Ultragenyx Pharmaceutical), are some of the most anticipated emerging therapies in the Rett Syndrome market.<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><strong>Neuren Pharmaceuticals, Acadia Pharmaceuticals, GW Research, Anavex Life Sciences, Ultragenyx Pharmaceutical<\/strong><span> are among the companies which are proactively working in the Rett Syndrome market.<\/span><\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>Want to know more? Request sample @<\/span><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/rett-syndrome-market?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Rett Syndrome Market Insights<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>The Rett Syndrome market report<\/span><span> covers current treatment methods, developing therapies, individual therapy market share, and present and predicted Rett Syndrome market size from 2018 to 2030, segmented into seven major markets.<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Rett Syndrome: Disease Overview<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>Rett Syndrome is a rare neurodevelopmental disorder that affects mostly females but can sometimes impact boys. It is first identified in infancy. It is caused by mutations in the MECP2 gene on the X-chromosome. On the MECP2 gene, there are over 200 distinct mutations. The majority of these mutations are concentrated in eight distinct &ldquo;hot spots.&rdquo; Autism, cerebral palsy, and global developmental delay are all common misdiagnoses for Rett syndrome. It affects people of all ethnic and racial backgrounds.<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Rett Syndrome Epidemiology Segmentation<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Rett Syndrome Prevalent Cases<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Rett Syndrome Gender-Specific Prevalent Cases<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Rett Syndrome Age-Specific Prevalent Cases<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Rett Syndrome Diagnosed and Treatable Cases<\/span><\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Rett Syndrome Treatment Landscape<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>There is currently no therapy available for the treatment of Rett syndrome on the market. Rett syndrome treatment is symptomatic, meaning it focuses on managing symptoms, which necessitates a multidisciplinary approach. The most common types of treatment for Rett Syndrome include:<\/span><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Speech-language therapy<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Physical Therapy<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Off-label Medications (bromocriptine, carbidopa-levodopa<\/span><span>, <\/span><span>levocarnitine, etc.)<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Hydrotherapy<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Diet Management<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Occupational Therapy<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Antidepressants (trazodone)<\/span><\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Rett Syndrome Market<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>The total market size for Rett Syndrome will comprise both upcoming therapies such as <\/span><span>NNZ-2566 (Trofinetide) (Neuren Pharmaceuticals\/Acadia Pharmaceuticals), GWP42003-P (Epidiolex) (GW Research), ANAVEX 2-73 (blarcamesine) (Anavex Life Sciences), Dojolvi (Ultragenyx Pharmaceutical)<\/span><span> and current treatment regimens, which will include many off-label medicines used in the seven major markets.<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>Learn more about Rett Syndrome @ <\/span><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/rett-syndrome-market?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Rett Syndrome Market Outlook and Treatment Landscape<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Rett Syndrome Pipeline Therapies and Key Companies<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>NNZ-2566 (Trofinetide): Neuren Pharmaceuticals\/Acadia Pharmaceuticals<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>GWP42003-P (Epidiolex): GW Research<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>ANAVEX 2-73 (blarcamesine): Anavex Life Sciences<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Dojolvi: Ultragenyx Pharmaceutical<\/span><\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Scope for the Report<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Coverage: <\/strong><span>7MM (the US, EU5 (the UK, Germany, Italy, Spain and France) and Japan)<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Study Period: <\/strong><span>2018-30<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Rett Syndrome Key Companies: <\/strong><span>Neuren Pharmaceuticals, Acadia Pharmaceuticals, GW Research, Anavex Life Sciences, Ultragenyx Pharmaceutical<\/span><span>,<\/span><span> among others.<\/span><span>&nbsp;<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Rett Syndrome Key Pipeline Therapies: <\/strong><span>NNZ-2566 (Trofinetide) (Neuren Pharmaceuticals\/Acadia Pharmaceuticals), GWP42003-P (Epidiolex) (GW Research), ANAVEX 2-73 (blarcamesine) (Anavex Life Sciences), Dojolvi (Ultragenyx Pharmaceutical)<\/span><span>,<\/span><span> and others.<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Rett Syndrome Market Segmentation: <\/strong><span>By Geography, By Rett Syndrome therapies<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Analysis: <\/strong><span>Comparative and conjoint analysis of Rett Syndrome emerging therapies<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Tools Used: <\/strong><span>SWOT Analysis<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Case Studies<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>KOL&rsquo;s Views<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Analyst&rsquo;s Views<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Table of Contents<\/strong><\/p>\n<div style=\"text-align: justify;\" dir=\"ltr\" align=\"left\">\n<table>\n<colgroup>\n<col width=\"65\" \/>\n<col width=\"559\" \/><\/colgroup>\n<tbody>\n<tr>\n<td>\n<p dir=\"ltr\"><span>1.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Report Introduction<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>2.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Rett Syndrome: Market Overview at a Glance<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>3.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Disease Background and Overview: Rett Syndrome<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>4.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Rett Syndrome Epidemiology and Patient Population<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>5.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Rett Syndrome: Country-Wise Epidemiology<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>6.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Rett Syndrome Treatments &amp; Medical Practices<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>7.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Rett Syndrome Emerging Therapies<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>8.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Rett Syndrome Key Cross Competition<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>9.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Rett Syndrome Market Size<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>10.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>7MM Rett Syndrome: Country-Wise Market Analysis<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>11.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Rett Syndrome United States Market Size<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>12.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Rett Syndrome EU5 Market Size<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>13.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Rett Syndrome Japan Market Size<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>14.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Report Methodology<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>15.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>DelveInsight Capabilities<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>16.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Disclaimer<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>17.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>About DelveInsight<\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>For rich insights into Healthcare and Pharmaceutical News, visit <\/span><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Pharma, Healthcare and Biotech Blog Posts<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Related Reports<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/alagille-syndrome-market?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Alagille Syndrome Market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>Get comprehensive historical and forecast analysis of <\/span><span>Alagille Syndrome Market<\/span><span>, Epidemiological and Therapeutics market domain with a special focus on key companies such as <\/span><strong>Mirum Pharmaceuticals, Albireo,&nbsp;<\/strong><span>among others.<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>About DelveInsight<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end to end comprehensive solutions to improve their performance.<\/span>&nbsp;<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com\/_57048.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Sandeep Joshi<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=the-dynamics-of-rett-syndrome-market-is-anticipated-to-change-in-the-upcoming-years-owing-to-the-improvement-in-the-research-and-development\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 9193216187<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Las Vegas<br \/><strong>State:<\/strong> NV<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"http:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">www.delveinsight.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"http:\/\/www.delveinsight.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=the-dynamics-of-rett-syndrome-market-is-anticipated-to-change-in-the-upcoming-years-owing-to-the-improvement-in-the-research-and-development\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Rett Syndrome Market The total market size for Rett Syndrome will include both emerging therapies, such as NNZ-2566 , GWP42003-P, ANAVEX 2-73 and Dojolvi, as well as current treatment regimens. The Rett Syndrome Market report&nbsp;from DelveInsight provides an in-depth understanding &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/the-dynamics-of-rett-syndrome-market-is-anticipated-to-change-in-the-upcoming-years-owing-to-the-improvement-in-the-research-and-development_547057.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[405,406,420,403,404],"tags":[],"class_list":["post-547057","post","type-post","status-publish","format-standard","hentry","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-Science","category-UK","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/547057","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=547057"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/547057\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=547057"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=547057"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=547057"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}